Great Point Partners 13F filings
Manager(s): Dr. Jeffrey Jay, M.D. and Mr. David Kroin
Holdings as of 2024-03-31
Filed on 2024-05-15 under CIK 1281446
Company
Investment Type
Change
Value (x$1000)
increase or decrease
NEUROGENE INC COM
1,004,291 sh
10,062 sh
1%
1%
$51,118
$31,850
ALPINE IMMUNE SCIENCES INC COM
1,128,499 sh
-2,574,934 sh
-70%
-70%
$44,734
-$25,853
UroGen Pharma Ltd. COM
2,620,545 sh
$39,308
Abivax SA F Sponsored ADR Stock
2,488,483 sh
938,483 sh
61%
61%
$35,585
$19,000
EVOLUS INC COM
2,450,000 sh
450,000 sh
23%
23%
$34,300
$13,240
Pliant Therapeutics Inc. COM
1,851,864 sh
28,680 sh
2%
2%
$27,593
-$5,425
APOGEE THERAPEUTICS INC COM
400,000 sh
$26,580
Aerovate Therapeutics Inc. COM
887,690 sh
-150,000 sh
-14%
-14%
$26,249
$2,766
VIRIDIAN THERAPEUTICS Common Stock
1,335,000 sh
1,335,000 sh
NEW
NEW
$23,376
$23,376
Esperion Therapeutics Inc COM
8,000,000 sh
8,000,000 sh
NEW
NEW
$21,440
$21,440
INSMED INC COM PAR $.01
775,585 sh
549,673 sh
243%
243%
$21,042
$14,041
XENON PHARMACEUTICALS INC COM
456,148 sh
-143,852 sh
-24%
-24%
$19,637
-$7,999
MIND MEDICINE MINDMED INC COM NEW Stock
2,000,000 sh
2,000,000 sh
NEW
NEW
$18,800
$18,800
DIANTHUS THERAPEUTICS INC COM
625,000 sh
625,000 sh
NEW
NEW
$18,750
$18,750
OUTLOOK THERAPEUTICS INC COM Common Stock
1,480,000 sh
1,480,000 sh
NEW
NEW
$17,671
$17,671
CYTOKINETICS INC COM NEW
202,202 sh
-297,798 sh
-60%
-60%
$14,176
-$27,569
JASPER THERAPEURITC, INC. Stock
407,550 sh
407,550 sh
NEW
NEW
$11,966
$11,966
INTRA CELLULAR THERAPIES INC COM
150,000 sh
39,393 sh
36%
36%
$10,380
$2,458
MERUS N V COM
223,288 sh
203,288 sh
1016%
1016%
$10,055
$9,505
VISTAGEN THERAPEUTICS ORD COM
1,858,735 sh
$9,814
Terns Pharmaceuticals Inc. COM
1,309,975 sh
$8,593
IMMUNOCORE HOLDINGS PLC-ADR (IMCR US) ADS
115,000 sh
-178,000 sh
-61%
-61%
$7,475
-$12,543
AUTOLUS THERAPEUTICS PLC SPON ADS
1,166,667 sh
1,166,667 sh
NEW
NEW
$7,443
$7,443
PUMA BIOTECHNOLOGY INC COM
1,343,628 sh
250,355 sh
23%
23%
$7,121
$2,387
ZURA BIO LTD CLASS A ORD SHS
2,757,740 sh
-537,260 sh
-16%
-16%
$7,087
-$8,301
HELIX ACQUISITION CORP II CL A ORD SHS
500,000 sh
500,000 sh
NEW
NEW
$5,200
$5,200
AEGLEA BIOTHERAPEUTICS INC cs
125,000 sh
$4,741
Kyverna Therapeutics, Inc. Common Stock
150,000 sh
150,000 sh
NEW
NEW
$3,726
$3,726
Arvinas Inc COM
71,113 sh
-162,969 sh
-70%
-70%
$2,936
-$6,699
Vaxcyte, Inc. COM
0 sh
-360,000 sh
-100%
-100%
$0
-$22,608
TOURMALINE BIO INC Common Stock
0 sh
-672,885 sh
-100%
-100%
$0
-$17,616
KARUNA THERAPEUTICS INC COM
0 sh
-30,250 sh
-100%
-100%
$0
-$9,574
AXSOME THERAPEUTICS INC COM
0 sh
-4,963 sh
-100%
-100%
$0
-$395
Mural Oncology PLC Common / Ordinary Stock
0 sh
-11,509 sh
-100%
-100%
$0
-$68